Welcome to your Daily Dose of Health Tech Innovation!
Stay ahead with the latest breakthroughs revolutionizing healthcare—from AI diagnostics to remote care solutions.
We bring you expert-curated insights, emerging trends, and must-know updates from the digital health frontier.
Whether you’re a clinician, innovator, or health tech enthusiast, this roundup delivers what matters most.
Let’s dive into the future of health, one innovation at a time.
ExQor Advances Brain Therapy for Alzheimer’s Clinical Trials
ExQor Technologies, a biotech firm based in Boston, is moving into an important stage of its mission to fight Alzheimer’s disease with a new brain healing treatment. They are getting ready for clinical trials after strong results from early research that suggest a new way to treat brain diseases. Unlike current medicines that just slow down the loss of mental abilities, ExQor’s method aims to fix the damage and help the brain repair itself. They also have another study planned for frontotemporal dementia, with more plans to expand into other conditions that affect the mind.
Pinnacol Assurance Names Dr. Gabriel Lockhart as Senior Medical Director
Pinnacol Assurance, Colorado’s leading workers’ compensation insurer, welcomes Gabriel Lockhart, M.D., M.B.A., as its new Sr. Medical Director. Dr. Lockhart’s extensive background in clinical leadership, quality improvement and equitable patient care will be instrumental in advancing Pinnacol’s commitment to providing best-in-class, compassionate medical treatment for Coloradans injured on the job.
KalVista Pharmaceuticals Appoints Bethany L. Sensenig to Board
KalVista Pharmaceuticals, Inc. announced the appointment of Bethany L. Sensenig to its Board of Directors, effective October 1, 2025. Along with joining the Board, Ms. Sensenig was named a member of the Audit Committee. In connection with this change, Nancy Stuart will step down from the Audit Committee but will remain on the Board and continue her role on the Nominating and Corporate Governance Committee. The Board also approved Ms. Stuart’s appointment to the Compensation Committee.
Interwell Health Welcomes CEO Tommy O’Connor to Accelerate Value-Based Kidney Care
Interwell Health, a leader in value-based kidney care, has appointed Tommy O’Connor as its new Chief Executive Officer. O’Connor brings extensive experience in healthcare leadership and will play a key role in furthering Interwell’s mission to transform kidney care through innovative solutions that improve patient outcomes while managing costs.
Nanyang Biologics to Go Public via $1.5 Billion Merger with RF Acquisition
On October 2nd, 2025, NYB announced that it entered into a business combination agreement with RF Acquisition Corp II , a publicly traded special purpose acquisition company, in a transaction aimed at making NYB become a publicly listed company . Following the closing, the combined company is expected to be listed on Nasdaq under the reserved ticker symbol “NYB.”
To share your insights, please write to us at sudipto@intentamplify.com
